312
Participants
Start Date
October 15, 2011
Primary Completion Date
May 29, 2024
Study Completion Date
May 29, 2024
Fingolimod
fingolimod 0.5 mg/day, including generic versions of fingolimod
Novartis Investigative Site, Roma
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Budapest
Novartis Investigative Site, Nicosia
Novartis Investigative Site, Maribor
Novartis Investigative Site, Brasschaat
Novartis Investigative Site, Leuven
Novartis Investigative Site, Bern
Novartis Investigative Site, Box Hill
Novartis Investigative Site, Linz
Novartis Investigative Site, Basel
Novartis Investigative Site, Sønderborg
Novartis Investigative Site, Bahía Blanca
Novartis Investigative Site, Graz
Novartis Investigative Site, Aalborg
Novartis Investigative Site, Sankt Gallen
Novartis Investigative Site, Orbassano
Novartis Investigative Site, Riyadh
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Novartis Investigative Site, Turku
Novartis Investigative Site, Jeddah
Novartis Investigative Site, Madrid
Novartis Investigative Site, Fort Lauderdale
Novartis Investigative Site, Seville
Novartis Investigative Site, Bochum
Novartis Investigative Site, Florence
Novartis Investigative Site, Cahors
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Grand Forks
Novartis Investigative Site, Bron
Novartis Investigative Site, Catania
Novartis Investigative Site, Moscow
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, Saint-Laurent
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Abu Dhabi
Novartis Investigative Site, Dubai
Novartis Investigative Site, Ostrava-Poruba
Novartis Investigative Site, Aarhus
Novartis Investigative Site, Copenhagen
Novartis Investigative Site, Tampere
Novartis Investigative Site, Athens
Novartis Investigative Site, Győr
Novartis Investigative Site, Dublin
Novartis Investigative Site, Beirut
Novartis Investigative Site, Mexico City
Novartis Investigative Site, Lubin
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Amadora
Novartis Investigative Site, Porto
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Newcastle upon Tyne
Novartis Investigative Site, Norwich
Novartis Investigative Site, Nottingham
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY